This Stream includes all Videos from our In Vivo Tools For Immunotherapy Drug Development Youtube playlist
Potency of PD-1+CTLA-4 BiSpecific or Combination in a Humanized Mouse Model Presented by Richard Stebbings, Ph.D. - Senior Director, Oncology Safety, AstraZeneca, Cambridge, United Kingdom Presented
Watch Video
Of mice and men - FcRn biology and its implications in a therapeutic perspective Presented by Jan Terje Andersen, Ph.D. - Professor in Biomedical Innovation, University of Oslo, Co-founder, Authera,
Watch Video
Preclinical Assessment of Engineered Immunoglobulins in Immune-humanized Mice Presented by Brian Soper, Ph.D. - Senior Scientific Engagement Manager, The Jackson Laboratory, Bar Harbor, USA Presen
Watch Video
In vivo CAR T cell generation in humanized mouse models Presented by Naphang Ho - Doctoral Candidate, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany
Watch Video
Of mice and men - FcRn biology and its implications in a therapeutic perspective Presented by Torleif Tollesfrud Gjølberg, Ph.D. - Scientist, University of Oslo Hospital, Co-founder, Authera, Norway
Watch Video
Cytokine release in the context of T cell bispecific antibody (TCB) therapies: biological mechanisms and mitigation strategies Presented by Gabrielle Leclerq, Ph.D. - Doctorate Scientist, Roche Phar
Watch Video
When is a potent antibody against a good target not a drug? The case for early PK Presented by Adam Drake, Ph.D. - Director In Vivo Pharmacology, Ichnos Sciences Biotherapeutics, SA, Switzerland Pre
Watch Video
